Unique ID issued by UMIN | UMIN000015382 |
---|---|
Receipt number | R000017896 |
Scientific Title | Evaluation of sodium carboxymethyl cellulose (SCMC) and hyaluronic acid (HA) as a local injection solution of endoscopic submucosal dissection for early gastric cancer;Randomized controlled trial |
Date of disclosure of the study information | 2014/10/14 |
Last modified on | 2020/11/28 16:50:12 |
Evaluation of sodium carboxymethyl cellulose (SCMC) and hyaluronic acid (HA) as a local injection solution of endoscopic submucosal dissection for early gastric cancer;Randomized controlled trial
RCT of ESD with SCMC or HA
Evaluation of sodium carboxymethyl cellulose (SCMC) and hyaluronic acid (HA) as a local injection solution of endoscopic submucosal dissection for early gastric cancer;Randomized controlled trial
RCT of ESD with SCMC or HA
Japan |
Early gastric cancer and gastric adenoma
Gastroenterology |
Malignancy
NO
The aim of this study is to evaluate the safety and efficacy of SCMC-ESD as compared to the HA-ESD of early gastric cancer and adenoma.
Safety,Efficacy
procedural time
1.The amount of local injection solution of HA or SCMC
2.Number of times of use of hemostatic forceps for stop bleeding
3.Status of ulcer healing
4.Bleeding rate
5.Incidence rate of adverse events related to ESD
6.En block resection rate
7.R0 resection rate
8.Blood test: WBC,CRP (next day)
9.Changes in body temperature
10.Evaluate of technically difficult (evaluated at 10 levels with a VAS score)
(10point: very easy, 1point: very difficult)
11.Change of local injection solution
12.Change of the operator
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
Numbered container method
2
Treatment
Maneuver |
Using SCMC as a for submucosal injection solution.
Using HA as a for submucosal injection solution.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1. Patient who will be performed ESD for gastric cancer or gastric adenoma.
2. Gastric neoplasms with indication of ESD.
3. Patient has no history of allergy to SCMC or HA.
4. ECOG performance status is 0 or 1 or 2.
5. Patient must sign an informed consent.
1.Psychosis
2.Patient who have synchronous lesion
3. Patients who cannot consent to use SCMC.
4. Patient with AP, Respiratory failure, Chronic hepatitis, Renal failure requiring dialysis, simultaneous cancer, continuous systemic steroid medication.
5. Patients with allergy to SCMC and HA.
6.Patients temporary interruption of antiplatlet agents and anticoagulants is not possible.
7.Patient under heparin replacement.
8.Patient who have been judged as psychotic manifestation.
60
1st name | Ohira |
Middle name | |
Last name | Hiromasa |
Fukushima Medical University School of Medicine
Department of Gastroenterology
960-1295
1 Hikarigaoka, Fukushima, Japan
024-547-1202
h-ohira@fmu.ac.jp
1st name | Nakamura |
Middle name | |
Last name | Jun |
Fukushima medical university
Endoscopy division
960-1295
1 Hikarigaoka, Fukushima, Japan
024-547-1583
junn7971@fmu.ac.jp
Fukushima Medical University School of Medicine, Department of Gastroenterology.
Fukushima Medical University School of Medicine, Department of Gastroenterology.
Self funding
IRB
1 Hikarigaoka, Fukushima, Japan
024-547-1825
junn7971@fmu.ac.jp
NO
福島県立医科大学部附属病院(福島県)
2014 | Year | 10 | Month | 14 | Day |
Published
60
Completed
2014 | Year | 09 | Month | 10 | Day |
2014 | Year | 09 | Month | 10 | Day |
2014 | Year | 10 | Month | 12 | Day |
2020 | Year | 10 | Month | 01 | Day |
2020 | Year | 10 | Month | 30 | Day |
2014 | Year | 10 | Month | 09 | Day |
2020 | Year | 11 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017896
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |